Investors never know what to expect for National Instruments
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on National Instruments with three of five analysts rating it hold. Analysts don't like National Instruments as much as competitor Synopsys overall. Seven out of seven analysts rate Synopsys a buy compared to two out of five for National Instruments. Analysts haven't adjusted their rating of National Instruments for the past three months.
- Revenue forecasts: On average, analysts predict $268.5 million in revenue this quarter. That would represent a rise of 21.8% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $0.22 per share. Estimates range from $0.20 to $0.24.
What our community says:
CAPS All-Stars are solidly behind the stock, with 98.9% granting it an outperform rating. The community at large backs the All-Stars, with 94.9% giving it a rating of outperform. Fools are gung-ho about National Instruments, though the message boards have been quiet lately, with only 71 posts in the past 30 days. Even with a robust four out of five stars, National Instruments' CAPS rating falls a little short of the community's upbeat outlook.
National Instruments' profit has risen year over year by an average of more than fivefold over the past five quarters.
For all our National Instruments-specific analysis, including earnings and beyond, add National Instruments to My Watchlist.
Motley Fool newsletter services have recommended buying shares of National Instruments. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.